BRIDGEWAY CAPITAL MANAGEMENT, LLC - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 23 filers reported holding ELIEM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$145,789
-5.7%
55,2230.0%0.00%0.0%
Q2 2023$154,624
-3.4%
55,2230.0%0.00%0.0%
Q1 2023$160,147
-19.0%
55,2230.0%0.00%
-20.0%
Q4 2022$197,698
+11.1%
55,2230.0%0.01%0.0%
Q3 2022$178,000
+187.1%
55,223
+170.4%
0.01%
+400.0%
Q2 2022$62,000
-59.7%
20,423
+11.0%
0.00%
-66.7%
Q1 2022$154,00018,4000.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RA Capital Management 13,150,849$236,452,0003.28%
Monashee Investment Management LLC 305,233$5,488,0001.01%
SAMLYN CAPITAL, LLC 1,681,025$30,225,0000.40%
Woodline Partners LP 387,224$6,962,0000.11%
TUDOR INVESTMENT CORP ET AL 287,294$5,166,0000.08%
CAAS CAPITAL MANAGEMENT LP 75,000$1,349,0000.03%
Hudson Bay Capital Management LP 100,000$1,798,0000.02%
GOLDMAN SACHS GROUP INC 165,952$2,984,0000.00%
HRT FINANCIAL LP 11,797$212,0000.00%
MILLENNIUM MANAGEMENT LLC 71,983$1,294,0000.00%
View complete list of ELIEM THERAPEUTICS INC shareholders